Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Hans-Reimer Rodewald has been elected EMBO Member

No. 19c | 31/05/2016 | by Koh

Hans-Reimer Rodewald from the German Cancer Research Center (DKFZ) has been elected to join the European Molecular Biology Organization (EMBO) in recognition of his research achievements in immunology. The more than 1,700 EMBO Members are internationally leading scientists in their fields.

Hans-Reimer Rodewald

Hans-Reimer Rodewald heads the Division of Cellular Immunology at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg. With his team, he is studying how immune cells and immunological organs develop and which defects in this process lead to diseases. Using mouse models, they investigate, among other things, how hematopoietic stem cells in the bone marrow work, how T cells mature in the thymus gland, how macrophages develop, and which functions mast cells have.

Rodewald and his colleagues discovered that precursor cells of T cells turn cancerous when they reside in the thymus for unnaturally long periods. This can happen when the supply of new precursors into the thymus is interrupted. In mice, the investigators were able to reveal the molecular mechanisms that lead to the spontaneous development of these T cell leukemias.  

Mast cells, which are probably the most enigmatic cells of the immune system, are another focus of Rodewald’s work. The role of mast cells in allergies is known – which other functions do they have? Researchers working with Rodewald bred mice whose immune systems are deficient of any mast cells while normal in all other respects. Using these animal models, the researchers studied many of the functions that have been attributed to mast cells to date.

In addition, researchers in Rodewald’s department were able to equip blood stem cells with a fluorescent marker that can be switched on from the outside. Thus, they were able, for the first time, to observe the development of blood cells from stem cells without cell transplantation in the living organism and to determine the dynamics of blood formation using these data.

Rodewald has published his research results in about one hundred scientific publications so far, many of them in the most prestigious specialist journals. In 2009, he received an Advanced Grant from the European Research Council (ERC).

Hans-Reimer Rodewald studied veterinary medicine in Hannover and subsequently did his doctorate at the Max Planck Institute of Immunobiology in Freiburg. Afterwards, he worked as a postdoctoral researcher at the Massachusetts Institute of Technology and at the Dana Farber Cancer Institute of Harvard Medical School. From 1992 to 1999, Rodewald was a member of the Basel Institute for Immunology. He subsequently accepted a professorship for Immunology at the University of Ulm. Since 2010, he has led the Division of Cellular Immunology at the German Cancer Research Center (DKFZ).

The science organization EMBO has promoted molecular biology research in Europe since 1964. New members are nominated and elected by other members in recognition of outstanding scientific achievements. Numerous EMBO Members have been awarded Nobel Prizes. Among them is Harald zur Hausen, who served as Chairman and Scientific Director of the DKFZ for many years and won the Nobel Prize in Medicine in 2008. This year, 58 life scientists have been honored with an EMBO membership.  

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.


Subscribe to our RSS-Feed.

to top
powered by webEdition CMS